North Star Investment Management Corp. Takeda Pharmaceutical CO LTD Transaction History

North Star Investment Management Corp.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$13.17 - $16.4 $3,371 - $4,198	-256 Closed	0 $0
Q4 2020 Jan 12, 2021	SELL	$15.39 - $18.97 $4,570 - $5,634	-297 Reduced 53.71%	256 $5,000
Q4 2019 Jan 29, 2020	SELL	$16.88 - $20.83 $3,392 - $4,186	-201 Reduced 26.66%	553 $11,000
Q3 2019 Oct 03, 2019	BUY	$16.15 - $17.99 $12,177 - $13,564	754 New	754 $13,000
Q2 2019 Jul 15, 2019	SELL	$16.58 - $20.49 $13,661 - $16,883	-824 Closed	0 $0
Q1 2019 Apr 10, 2019	BUY	$16.7 - $21.52 $13,760 - $17,732	824 New	824 $17,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.